Hologic stock exits Nasdaq after USD 76.00 buyout closes
Published on 09/29/2026 at 17:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hologic stock exited Nasdaq after the company became privately owned on April 7, 2026. According to Multiples, stockholders received USD 76.00 in cash plus a non-tradable contingent value right worth up to USD 3.00 per share.
USD 76.00 cash set the terms
The consideration put a clear number on the final public-market value of Hologic shares. The same transaction was valued at up to USD 18.3 billion, giving investors a concrete reference for the company before its listing ended.
The CVR links the additional USD 3.00 potential payment to future revenue performance in Hologic's Breast Health business, according to Multiples. That structure separates the guaranteed cash component from the performance-linked element.
Private ownership changes the stock story
BriefGlance reported that Hologic's common stock ceased trading on Nasdaq after the April 2026 acquisition by funds managed by Blackstone and TPG. Jose E. Almeida became chief executive officer after the transaction, succeeding Stephen P. MacMillan.
That change removes the usual public-market checkpoints for Hologic. The company now operates as a private medical technology business, while its four core areas remain Diagnostics, Breast Health, GYN Surgical and Skeletal Health, according to Hologic.
Diagnostics remain a measurable growth area
Hologic's September 24, 2026 update highlighted its Breast Cancer Index test. BriefGlance reported that the test changed extended endocrine therapy recommendations for 42 percent of patients in a study update.
Hologic says it was founded in 1985 and has more than 4,100 patents across its women's health technologies. Its portfolio includes diagnostic tests, medical imaging systems and surgical solutions used by laboratories, hospitals and healthcare providers.
The Nasdaq chapter ended April 7
Hologic's public listing ended on April 7, 2026, when the Blackstone and TPG transaction closed. The USD 76.00 cash payment, the potential USD 3.00 CVR and the up to USD 18.3 billion transaction value now define the final listed-company reference for Hologic stock.
Hologic stock facts
- Company: Hologic, Inc.
- ISIN: US4364401012
- Ticker: HOLX
- Primary exchange: Nasdaq, former listing
- Sector / Industry: Healthcare / Medical technology
- Transaction consideration: USD 76.00 cash plus a CVR of up to USD 3.00 per share
- Transaction date: April 7, 2026
